Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
DNA vaccine
Biotech
Inovio drops Lassa, MERS vaccines as clinical data fall short
The vaccine candidates have fallen short of the bar set by the biotech’s partner, prompting the collaborators to pull the plug on the programs.
Nick Paul Taylor
Nov 18, 2022 5:25am
Inovio CEO departs, leaving Jacqueline Shea in charge
May 11, 2022 10:00am
Inovio pauses COVID-19 vaccine trial, seeks endpoint switch
Mar 2, 2022 7:40am
DNA vaccine spurs antibodies against Parkinson's target in mice
Jan 18, 2022 8:50am
A DNA COVID-19 vaccine shows early promise
May 27, 2021 2:00pm
Inovio's COVID-19 vaccine runs into FDA hold
Sep 28, 2020 9:35am
